Effect of Beta-adrenergic Blockers on Cardiac Function, Systemic &

See also
Status	Clinical Trial	Phase
Completed	`NCT01349348` - Phase III Study of Tolvaptan Tablet to Treat Cirrhosis Ascites	Phase 3
Active, not recruiting	`NCT04682847` - Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic Cancers
Recruiting	`NCT05904470` - A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV	Phase 2
Completed	`NCT02138253` - A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV	Phase 2
Recruiting	`NCT02652351` - Human Umbilical Cord-Mesenchymal Stem Cells for Hepatic Cirrhosis	Phase 1
Completed	`NCT00794482` - Multi-national Cirrhosis Study to Characterise the Association Between the Pharmacokinetics of NRL972 and Disease Severity.	Phase 3
Completed	`NCT00856713` - Clearance of NRL972 in Patients With Cirrhosis and in Healthy Volunteers	Phase 1
Completed	`NCT00857480` - Evaluation of the PK of NRL972 Following Pre- and co-Administration of Ursodeoxycholic Acid and Cloxacillin	Phase 1
Completed	`NCT00006164` - Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment	Phase 3
Completed	`NCT03486912` - A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis	Phase 2
Completed	`NCT00698464` - Pharmacokinetics and Safety of Single Subcutaneous Pasireotide (SOM230) in Subjects With Varying Degrees of Hepatic Function	Phase 1
Completed	`NCT02778425` - The Treatment of Hepatocirrhosis and Portal Hypertension	N/A
Completed	`NCT03420768` - A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis C	Phase 2
Completed	`NCT03445208` - A Study of Experimental Medication BMS-986036 Given to Healthy Participants	Phase 1
Completed	`NCT03804593` - HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC)
Completed	`NCT03712280` - MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)	Phase 2
Completed	`NCT02230670` - A Study of IDN-6556 in Subjects With Liver Cirrhosis	Phase 2
Completed	`NCT02230683` - A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension	Phase 2
Completed	`NCT01135628` - Hyperproteic Diet Plus Lactobacillus Reuteri and Nitazoxanide in Minimal Hepatic Encephalopathy	N/A
Completed	`NCT00856869` - Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy Volunteers	Phase 1/Phase 2

NCT number	NCT02163512
Study type	Observational
Source	Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Contact
Status	Completed
Phase
Start date	March 12, 2014
Completion date	May 2018

Effect of Beta-adrenergic Blockers on Cardiac Function, Systemic and Splanchnic Haemodynamic and Kidney Function in Cirrhotic Patiets With Refractory Ascites — ALB-BET

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms